Literature DB >> 6832627

Leucocyte migration inhibition test in coeliac disease - a reappraisal.

F G Simpson, H P Field, P D Howdle, D A Robertson, M S Losowsky.   

Abstract

Results of the direct leucocyte migration inhibition (LMI) test using gluten fraction III as antigen were unaffected by incorporation of puromycin into the culture medium at concentrations shown to prevent lymphokine mediated inhibition. Results of the LMI test performed with purified polymorphs were similar to and correlated with results of the standard LMI test using mixed leucocytes in both coeliacs and controls. The addition of purified T lymphocytes did not increase migration inhibition. Normal leucocytes incubated with serum from coeliac patients and washed showed marked migration inhibition when incubated with gluten fraction III. This sensitisation of normal leucocytes was prevented by preincubation with aggregated human IgG. These results suggest that leucocyte migration inhibition by gluten in coeliac disease is not due to lymphokine production by sensitised lymphocytes but is caused by cytophilic antibody.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6832627      PMCID: PMC1419961          DOI: 10.1136/gut.24.4.311

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  25 in total

1.  CYTOTOXIC TEST FOR DEMONSTRATION OF MOUSE ANTIBODY.

Authors:  E A BOYSE; L J OLD; I CHOUROULINKOV
Journal:  Methods Med Res       Date:  1964

2.  Gluten-induced enteropathy: the effect of partially digested gluten.

Authors:  A C FRAZER; R F FLETCHER; C A ROSS; B SHAW; H G SAMMONS; R SCHNEIDER
Journal:  Lancet       Date:  1959-09-05       Impact factor: 79.321

3.  Use of antibody-coated red cells for the sensitive detection of antigen and in rosette tests for cells bearing surface immunoglobulins.

Authors:  N R Ling; S Bishop
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

4.  Superiority of corpuscular BCG to soluble PPD antigen in the leucocyte migration assay.

Authors:  A J Górski
Journal:  Clin Exp Immunol       Date:  1974-09       Impact factor: 4.330

5.  Immune responses to thyroglobulin in experimental allergic thyroiditis.

Authors:  J Wasserman; T Packalén
Journal:  Immunology       Date:  1965-07       Impact factor: 7.397

6.  Gluten and lymphocyte sensitisation in coeliac disease.

Authors:  F R Douwes
Journal:  Lancet       Date:  1976-12-18       Impact factor: 79.321

7.  Cell-mediated immunity to gluten fraction III in adult coeliac disease.

Authors:  A W Bullen; M S Losowsky
Journal:  Gut       Date:  1978-02       Impact factor: 23.059

8.  An in-vitro immunological assay for diagnosis of coeliac disease.

Authors:  A Ashkenazi; D Idar; Z T Handzel; M Ofarim; S Levin
Journal:  Lancet       Date:  1978-03-25       Impact factor: 79.321

9.  Studies on the inhibition of macrophage migration induced by soluble antigen-antibody complexes.

Authors:  P Kotkes; E Pick
Journal:  Clin Exp Immunol       Date:  1975-01       Impact factor: 4.330

10.  The effect of cytophilic IgG2 on phagocytosis by ovine polymorphonuclear leucocytes.

Authors:  D L Watson
Journal:  Immunology       Date:  1976-08       Impact factor: 7.397

View more
  3 in total

1.  Macrophage procoagulant activity as an assay of cellular hypersensitivity to gluten peptides in coeliac disease.

Authors:  J M Devery; C L Geczy; D DeClarle; J H Skerritt; S A Krillis
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

2.  The distribution of gluten-sensitive lymphocytes in coeliac patients--is it related to dietary gluten?

Authors:  P D Howdle; F G Simpson; M S Losowsky
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

3.  Cellular hypersensitivity to gluten derived peptides in coeliac disease.

Authors:  R Guan; P M Rawcliffe; J D Priddle; D P Jewell
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.